Changes in Taste Perception, Eating Habits, and Other Behavioral Aspects Associated With the Use of GLP-1 Receptor Agonists in Patients Undergoing Weight Loss Treatment: A Retrospective Observational Study.
Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY
This observational retrospective study aims to evaluate changes in taste perception, eating habits, and behavioral aspects in adults treated with GLP-1 receptor agonists for weight loss. Participants include adults aged 18-60 receiving treatment at specialized nutrition centers in Italy. Data are collected from clinical records, dietary questionnaires, and metabolic assessments before and after at least 12 weeks of GLP-1 agonist treatment. The study's primary goal is to understand how these treatments affect food preferences and taste perception. Secondary outcomes include changes in body weight, body composition, gastrointestinal side effects, and treatment adherence. All data are anonymized and collected according to ethical guidelines.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
Locations
Other Locations
Italy
San Raffaele Open University
RECRUITING
Roma
Department for the Promotion of Human Science and Quality of Life San Raffaele Open University
RECRUITING
Rome
San Raffaele Open University
RECRUITING
Rome
San Raffaele Open University
ACTIVE_NOT_RECRUITING
Rome
Contact Information
Primary
Mauro Lombardo, MD
mauro.lombardo@uniroma5.it
+393899740197
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2028-01-01
Participants
Target number of participants: 150
Treatments
GLP-1 Agonist Treated Patients
This cohort includes adult patients aged 18-60 who have been treated with GLP-1 receptor agonists such as semaglutide or tirzepatide for weight loss in specialized nutrition centers in Italy. The study collects retrospective data on changes in taste perception, eating habits, body composition, and treatment adherence over a minimum duration of 12 weeks of therapy. No interventional treatments are administered as part of this observational study.
Related Therapeutic Areas
Sponsors
Leads: San Raffaele Telematic University